Amgen, a leading biopharmaceutical company, has recently transitioned its enterprise AI tool from Microsoft's Copilot to OpenAI's ChatGPT. This strategic shift underscores the intensifying competition between Microsoft and OpenAI in the enterprise AI market.
Amgen's decision to adopt ChatGPT was...
aiai adoption
ai ecosystem
ai in business
ai industry trends
ai innovation
ai integration
ai platforms
ai research
ai technological advances
ai user experience
biopharmaceuticalai
chatgpt
corporate ai strategies
enterprise ai
enterprise software
microsoft copilot
openai
